Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Webster

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Disability and Rehabilitation|April 22, 2022
School-based allied health interventions for children and young people affected by neurodisability: a systematic evidence mapJennifer McAnuff, Jenny L Gibson, Rob Webster, et al.
Bioanalysis|September 11, 2018
Quantitative biodistribution of biotherapeutics at whole body, organ and cellular levels by autoradiographyMengmeng Wang, Yutian Zhan, Shawn P O'Neil, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Pyrazole NNRTIs 1: design and initial optimisation of a novel templateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Chemical Biology & Drug Design|March 1, 2011
Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomersLyn H Jones, Gill Allan, Romuald Corbau, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
Molecular Pharmaceutics|April 7, 2012
Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologiesVictoria L Elliott, George T Edge, Marie M Phelan, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
Pyrazole NNRTIs 3: optimisation of physicochemical propertiesCharles E Mowbray, Romuald Corbau, Michael Hawes, et al.
Cells|April 9, 2014
CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And CharacterizationRebecca J Platt, Tansi Khodai, Tim J Townend, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086Chuenlei Parng, Pratap Singh, Debra D Pittman, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Disability and Rehabilitation|April 22, 2022
School-based allied health interventions for children and young people affected by neurodisability: a systematic evidence mapJennifer McAnuff, Jenny L Gibson, Rob Webster, et al.
Bioanalysis|September 11, 2018
Quantitative biodistribution of biotherapeutics at whole body, organ and cellular levels by autoradiographyMengmeng Wang, Yutian Zhan, Shawn P O'Neil, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Pyrazole NNRTIs 1: design and initial optimisation of a novel templateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Chemical Biology & Drug Design|March 1, 2011
Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomersLyn H Jones, Gill Allan, Romuald Corbau, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
Molecular Pharmaceutics|April 7, 2012
Evidence for metabolic cleavage of a PEGylated protein in vivo using multiple analytical methodologiesVictoria L Elliott, George T Edge, Marie M Phelan, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
Pyrazole NNRTIs 3: optimisation of physicochemical propertiesCharles E Mowbray, Romuald Corbau, Michael Hawes, et al.
Cells|April 9, 2014
CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And CharacterizationRebecca J Platt, Tansi Khodai, Tim J Townend, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086Chuenlei Parng, Pratap Singh, Debra D Pittman, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
Pageof 3